Altropane, a SPECT or PET imaging probe for dopamine neurons: II. Distribution to dopamine-rich regions of primate brain

Synapse

Volumn 29, Issue 2, 1998, Pages 105-115

  Madras, Bertha K ^a   Gracz, Lawrence M ^a   Meltzer, Peter C ^b   Liang, Anna Y ^b   Elmaleh, David R ^c   Kaufman, Marc J ^a   Fischman, Alan J ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ORGANIX INC   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Aging; Cocaine; Dopamine neurons; Dopamine transporter; Neurodegenerative diseases; Parkinson's disease; PET imaging; SPECT imaging; WIN 35,428

Indexed keywords

ALTROPANE; COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; IODINE 125; SEROTONIN TRANSPORTER; TROPANE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CAUDATE NUCLEUS; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DRUG DISTRIBUTION; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SQUIRREL MONKEY;

ANIMALS; AUTORADIOGRAPHY; BRAIN; BRAIN CHEMISTRY; CARRIER PROTEINS; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; IODINE RADIOISOTOPES; LIGANDS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RECEPTORS, DOPAMINE D1; SAIMIRI; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031920217     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199806)29:2<105::AID-SYN2>3.0.CO;2-B     Document Type: Article

References (61)

1. 3H]GBR 12935 binding in vivo in mouse brain: Labelling of a piperazine acceptor site. Eur. J. Pharmacol., 144:1-6.
2. 125I]RTI-SS to dopamine and serotonin transporters in rat brain. Synapse, 12:27-36.
3. Brownell, A.-L., Elmaleh, D.R., Meltzer, P.C., Shoup, T.M., Brownell, G.L., Fischman, A. J., and Madras, B.K. (1996) Cocaine congeners as PET imaging probes for dopamine terminals. J. Nucl. Med., 37:1186-1192.
4. 3H]CFT in monkey brain. Synapse, 5:189-195.
5. Cerruti, C., Walther, D.M., Kuhar, M.J., and Uhl, G.R. (1993) Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain. Mol. Brain Res., 18:181-186.
6. Ciliax, B.J., Heilman, C., Demchyshyn, L.L., Pristupa, Z.B., Ince, E., Hersch, S.M., Niznik, H.B., and Levey, A.I. (1995) The dopamine transporter: Immunochemical characterization and localization in brain. J. Neurosci., 15:1714-1723.
7. Clarke, R.L., Daum, S.J., Gambino, A.J., Aceto, M.D., Pearl, J., Levitt, M., Cumiskey, W.R., Bogado, E.F. (1973) Compounds affecting the central nervous system. 4. 3β-phenyltropane-2-carboxylic esters and analogs. J. Med. Chem., 16:1260-1267.
8. 125I] RTI-55 to dopamine transporters: Pharmacology and regional distribution with autoradiography. Synapse, 12:37-46.
9. Elmaleh, D.R., Fischman, A.J., Shoup, T.M., Byon, C., Hanson, R.N., Liang, A.Y., Meltzer, P.C., and Madras, B.K. (1996) Preparation and biological evaluation of iodine-125-IACFT: A selective SPECT agent for imaging dopamine transporter sites. J. Nucl. Med., 37:1197-1202.
10. Emmers, R., and Akert, K. (1963) A Stereotaxic Atlas of the Brain of the Squirrel Monkey (Saimiri Sciureus). University of Wisconsin Press, Madison.
11. Emond, P., Garreau, L., Chalon, S., Boazi, M., Caillet, M., Bricard, J., Frangin, Y., Mauclaire, L., Besnard, J.-C., and Guilloteau, D. (1997) Synthesis and ligand binding of nortropane derivatives: N-substituted 2β-carbomethoxy-3β-(4′-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)-2β-carbomethoxy-3β-(3′,4′- disubstituted phenyl)nortropane. New high-affinity and selective compounds for the dopamine transporter. J. Med. Chem., 40:1366-1372.
12. 11C]β-CIT binding to monoamine transporters in the monkey and human brain. Synapse 16:93-193.
13. 123I]IACFT): Initial experience in humans. Neuroscience-Net, 1: Article #00010, HTTP://www.Neuroscienc.com
14. Fischman, A.J., Babich, J.W., Elmaleh, D.R., Barrow. S.A., Meltzer, P.C., and Madras, B.K. (1997) SPECT imaging of dopamine transporter sites in normal and MPTP treated rhesus monkeys. J. Nucl. Med., 38:144-150.
15. Fischman, A.J., Bonab, A.A., Babich, J.W., Palmer, P., Alpert, N.M., Elmaleh, D.R., Barrow, S.A., Graham, W., Meltzer, P.C., Hanson, R.H., and Madras, B.K. (1998) Rapid detection of Parkinson's disease by SPECT with Altropane: A selective ligand for dopamine transporters. Synapse, 29:128-141.
16. 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann. Neurol., 34:423-431.
17. Gash, D.M., Zhang, Z., Ovadia, A., Cass, W.A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P.A., Collins, F., Hoffer, B.J., and Gerhardt, G.A. (1997) Functional recovery in parkinsonian monkeys treated with GDNF. Nature, 380:252-255.
18. Gergen, J.A., and McLean, P.D. (1962) A Stereotaxic Atlas of the Squirrel Monkey's Brain (Saimiri Sciureus). Public Health Service Publication No. 933, Bethesda, MD.
19. Goodman, M.M., Kung, M.-P., Kabalka, G.W., Kung, H.F., and Switzer, R. (1994) Synthesis and characterization of radioiodinated N-(3-Iodopropen-1-yl)-2β-carbomethoxy-3β-(4-chlorophenyl)tropanes: Potential dopamine reuptake site imaging agents. J. Med. Chem., 37:1535-1542.
20. Goodman, M.M., Keil, R., Shoup, T.M., Eshima, D., Eshima, L., Kilts, C.L., Votaw, J., Camp, V.M., Votaw, D., Smith, E., Kung, M.-P., Malveaux, E., Watts, R., Huerkamp, M., Wu, D., Garcia, E., and Hoffman, J.M. (1997) Fluorine-18-FPCT: A PET radiotracer for imaging dopamine transporters. J. Nucl. Med., 38:119-126.
21. Halldin, C., Farde, L., Lundkvist, C., Ginovart, N., Nakashima, Y., karlsson, P., and Swahn, C.G. (1996) [11C]Beta-CIT-FE, a radioligand for quantification of the dopamine transporter in the living brain using positron emission tomography. Synapse, 22:396-390.
22. 11C]-CFT and PET in a primate model of parkinsonism. Neuroreport, 3:265-268.
23. Hume, S.P., Luthra, S.K., Brown, D.J., Opacka-Juffry, J., Osman, S., Ashworth, S., Myers, R., Brady, F., Carroll, F.I., Kuhar, M.J., and Brooks, D.J. (1996) Evaluation of [11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter. Nucl. Med. Biol. 23:377-384.
24. Innis, R.B., Seibyl, J.P., Scanley, B.E., Laruelle, M., Abi-Dargham, A., Wallace, E., Baldwin, R.M., Zea-Ponce, Y., Zoghbi, S., Wang, S., Gao, Y., Neumeyer, J.L., Charney, D.S., Hoffer, P.B., and Marek, K.L. (1993) Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease. Proc. Natl. Acad. Sci. USA, 90:11965-11969.
25. 3H]Mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Mol. Pharmacol., 26:35-44.
26. Kaufman, M.J., and Madras, B.K. (1991) Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's diseased striatum. Synapse, 9:43-49.
27. 125I] RTI-55. Synapse, 12:99-111.
28. 3H]CFT. Synapse, 9:177-187.
29. Kuhar, M.J., Sanchez-Roa, P.M., Wong, D.F., Dannals, D.F., Grigoriadis, D.E., Lew, R., and Milberger, M. (1990) Dopamine transporter: Biochemistry, pharmacology and imaging. Eur. Neurol., 30:15-20.
30. 123I]β-CIT: Pharmacological characterization of brain uptake in nonhuman primates. Synapse, 13:295-309.
31. 125I]RTI-121). Nucl. Med. Biol. 23:277-284.
32. 3H]WIN 35,428 binding sites in human striatum. Brain Res., 628:17-25.
33. Madras, B,K., and Kaufman, M.J. (1994) Cocaine accumulates in dopamine-rich regions of primate brain after i.v. administration: Comparison with mazindol distribution. Synapse, 18:261-275.
34. 3H]2β-carbomethoxy-3β-(4-fluorophenylltropane. Mol. Pharmacol.,36:518-524.
35. 3H]cocaine receptors. Pharmacol. Biochem. Behav., 35:949-953.
36. 125I]altropane was presented at an NIDA symposium, in conjunction with the annual meeting of the College on Problems of Drug Dependence, Keystone CO.
37. Madras, B.K., Elmaleh, D.E., Meltzer, P.C., Brownell, A.-L. (1994) Positron emission tomography of the dopamine transporter. NIDA Res. Mongraph., 138. In: Imaging Techniques in Medications Development: Preclinical and Clinical Aspects. H. Sorer and R.S. Rapaka, eds., pp. 57-69.
38. Madras, B.K., Gracz, L.M., Kaufman, M.J., Meltzer, P.C., Elmaleh, D.H., and Fischman, A.J. (1995) A novel SPECT imaging agent detects total loss of the dopamine transporter in parkinsonian monkeys. Soc. Neurosci. Abst., 21:1983.
39. 99mtechnetium probe to label the dopamine transporter in brain. Synapse, 22:239-246.
40. Madras, B.K., Kaufman, M.J., Fahey, M.A., Meltzer, P.C., Liang, A.Y., Hanson, R., Elmaleh, D.E., Babich, J., and Fischman, A.J. (1998a) [125I]Altropane, a SPECT imaging probe for dopamine neurons: I. Dopamine transporter binding in primate brain. Synapse,
41. 125I]Altropane, a SPECT imaging probe for dopamine neurons. III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain. Synapse,
42. Maggos, C.E., Spangler, R., Zhou, Y., Schlussman, S.D., Ho, A., and Kreek, M.J. (1997) Quantitation of dopamine transporter mRNA in the rat brain: Mapping, effects of "binge" cocaine administration and withdrawal. Synapse, 26:55-61.
43. Meegalla, S.K., Plossl, K., Kung, M.-P., Chumpradit, S., Stevenson, D.A., Kushner, S.A., McElgin, W.T., Mozley, P.D., and Kung, H.F. (1997) Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents. J. Med. Chem., 40:9-17.
44. 99mSPECT imaging agent which targets the dopamine transporter in primate brain. J. Med. Chem., 40:1835-1844.
45. Nirenberg, M.J., Chan, J., Vaughn, R.A., Uhl, G.R., Kuhar, M.J., and Pickel, V.M. (1997) Immunogold localization of the dopamine transporter: An ultrastructural study of the rat ventral tegmental area. J. Neurosci., 17:5255-5262.
46. Pilotte, N.S., Sharpe, L.G., and Kuhar, M.J. (1994) Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats. J. Pharmacol. Exp. Ther, 269:963-969.
47. Pilotte, N.S., Sharpe, L.G., Rountree, S.D., and Kuhar, M.J. (1996) Cocaine withdrawal reduces dopamine transporter binding in the shell of the nucleus accumbens. Synapse, 22:87-92.
48. Revay, R., Vaughn, R., Grant, S., and Kuhar, M.J. (1996) Dopamine transporter immunohistochemistry in median eminence, amygdala and other areas of the rat brain. Synapse, 22:93-99.
49. 11C]β-CFT in early Parkinson's disease. Synapse, 21:97-103.
50. Scheffel, U., Lever, J.R., Abraham, P., Parham, K.R., Mathews, W.B., Kopajtic, T., Carroll, F.I., and Kuhar, M.J. (1997) N-substituted phenyltropanes as in vivo binding ligands for rapid imaging studies of the dopamine transporter. Synapse, 25:345-349.
51. 123I]β-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann. Neurol., 38:589-598.
52. Staley, J.K., Hearn, W.L., Ruttenber, A.J., Wetli, C.V., and Mash, D.C. (1994) High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J. Pharmacol. Exp. Ther., 271:1678-1685.
53. Staley, J.K., Boja, J.W., Carroll, I.V., Seltzman, H.H., Wyrick, C.D., Lewin, A.H., and Abraham, P. (1995) Mapping dopamine transporters in human brain with novel selective cocaine analog [125I]RTI-121. Synapse, 21:364-372.
54. Stathis, M., Scheffel, U., Lever, S.Z., Boja, J.W., Carroll, F.I., and Kuhar, M.J. (1995) Rate of binding of various inhibitors at the dopamine transporter in vivo. Pyschopharmacology, 119:376-384.
55. Steiner, J.P., Hamilton, G.S., Ross, D.T., Valentine, H.L., Guo, H., Connolly, M.A., Ramsey, C., Li, J.-H.J., Huang, W., Howorth, P., Soni, R., Fuller, M., Sauer, H., Nowotnik, A.C., and Suzdak, P.D. (1997) Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc. Natl. Acad. Sci. USA, 94:2019-2024.
56. van Dyck, C.H., Seibyl, J.P., Malison, R.T., Laruelle, M., Wallace, E., Zoghbi, S.S., Zea-Ponce, Y., Baldwin, R.M., Charney, D.S., Hoffer, P.B., and Innis, R.B. (1995) Age-related decline in striatal dopamine transporter binding with iodine-123-β-CIT SPECT. J. Nucl. Med., 36:1175-1181.
57. Vaughan, R.A., Brown, V.L., McCoy, M.T., and Kuhar, M.J. (1996) Species- and brain region-specific dopamine transporters: Immunological and glycosylation characteristics. J. Neurochem., 66:2146-2152.
58. Volkow, N.D., Gatley, S.J., Fowler, J.S., Chen, R., Logan, J., Dewey, S.L., Ding, Y.-S., Pappas, N., King, P., MacGregor, R.R., Kuhar, M.J., Carroll, F.I., and Wolf, A.P. (1995) Long-lasting inhibition of in vivo cocaine binding to dopamine transporters by 3β-(4-iodophenyl)tropane-2-carboxylic acid methyl ester: RTI-55 or β-CIT. Synapse, 19:206-211.
59. Volkow, N.D., Wang, G.-J., Fowler, J.S., Gatley, S.J., Ding, Y.-S., Logan, J., Dewey, S.L., Hitzemann, R., and Lieberman, J. (1996) Relationship between psychostimulant-induced "high" and dopamine transporter occupancy. Proc. Natl. Acad. Sci. USA, 93:10388-10392.
60. 11C]WIN 35,428. Synapse, 15:130-142.
61. Zetterstrom, R.H., Solomin, L., Jansson, L., Hoffer, B.J., Olson, L., and Perlmann, T. (1997). Dopamine neuron agensis in Nurr1-deficient mice. Science, 276:248-250.